Bauchi, Nigeria – In a significant move to enhance healthcare outcomes in Nigeria, NSIA Advanced Medical Services Limited (MedServe) flagged off the first phase of its healthcare expansion programme to establish 23 diagnostic centres, 3 additional oncology centres and 7 cathetherization laboratories across the six geo-political zones of Nigeria.
The Managing Director & Chief Executive Officer of NSIA, Aminu Umar-Sadiq, and MD of MedServe, Dr. Tolulope Adewole, attended the groundbreaking ceremony for the first phase of the MedServe healthcare expansion project at the Abubakar Tafawa Balewa University Teaching Hospital in Bauchi State. Bauchi State Governor Senator Bala Mohammed, Minister of Finance and Coordinating Minister of the Economy Wale Edun, Coordinating Minister of Health & Social Welfare Prof. Ali Muhammed Pate, and other senior government officials joined them.
Moreover, The first phase of the healthcare expansion project aims to establish diagnostics and oncology centres in 10 locations including Bauchi, Enugu, Kaduna, Sokoto, Oyo, Akwa Ibom, Delta, Kwara, Plateau and Yobe states respectively.
The expansion project will leverage MedServe’s experience gained from successfully operating three demonstration projects namely: NSIA-LUTH Cancer Centre (NLCC), NSIA-Kano Diagnostic Centre (NKDC), NSIA-Umuahia Diagnostic Centre ( NUDC) located within the Lagos University Teaching Hospital (LUTH), the Aminu Kano Teaching Hospital (AKTH) and the Federal Medical Centre in Umuahia respectively.
While speaking at the ceremony, the Managing Director and Chief Executive, NSIA Aminu Umar Sadiq, described the groundbreaking as the culmination of five years of resilience and hard work, underpinned by a vision to birth what was once deemed impossible. “Over the ensuing five years, we have perfected the business model in terms of governance structure, pricing, recruitment and training of key personnel, and the patient experience,” he said.
Aside from the envisaged financial returns to MedServe, the healthcare expansion programme will deliver substantial socio-economic impact within Nigeria through expanded access to improved screening and diagnostics for communicable and non-communicable diseases, reduced cancer related mortality rates and considerable employment opportunities for key personnel within the oncology and diagnostics value chain in Nigeria.
Also Read: In world first, Nigeria introduces new 5-in-1 vaccine against meningitis
Furthermore, The Managing Director of MedServe, Dr Tolulope Adewole at the ceremony re-affirmed MedServe’s commitment to optimize oncology care by the creation of three additional oncology centres, strategic collaboration with key stakeholders to deepen capacity and partnerships with Original Equipment Manufacturers to improve patient outcomes.
